secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2021-12-27T23:59:59+00:00
Accession:  0001100682-21-000028
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CRL grants $5M long-term equity award to EVP LaPlume with 5-year cliff vesting and rTSR PSUs
--------------------------------------------------------------------------------

- Joseph W. LaPlume receives $5M total fair value: 50% RSUs (6,771 units) cliff vesting Dec 25, 2026.
- 50% in PSUs (5,096 target) based on 5-year relative TSR vs S&P Healthcare 500, payout 0%-200%.
- Grant effective Dec 25, 2021; recognizes LaPlume's contributions and critical role in strategic growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000110068221000028/0001100682-21-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000110068221000028/crl-20211222.htm
  HTML page:      https://secwatch.observer/filing/0001100682-21-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer